Metabolomics Workbench : NIH Data Repository

Log in / Register

Clustering data with hclust algorithm for (Study ST003936)

HILIC POSITIVE ION MODE (Analysis AN006480)

Metabolite	Structure	F1	F2	F3	F4	F5	F6	F7	F8	F9	F10	F11	F12	F13	F14	F15	F16	F17	F18
Glu	ME1044607	0.91	0.80	1.14	1.57	0.90	1.34	0.57	2.11	0.73	1.35	0.93	0.95	0.87	0.85	0.71	0.65	0.73	0.96
Gly	ME1044605	0.99	1.28	1.16	0.99	0.86	0.88	0.99	0.72	0.75	1.14	0.93	0.93	1.34	1.21	0.89	1.00	0.89	1.09
Trp	ME1044594	0.95	1.27	1.18	1.07	0.92	0.97	1.11	0.61	0.72	1.20	1.01	1.05	1.10	1.00	0.78	1.06	0.76	1.00
Arg	ME1044609	1.01	1.15	0.79	1.06	1.08	0.80	1.00	1.03	1.07	1.01	0.99	0.99	1.05	1.02	0.95	0.84	0.92	1.15
Phe	ME1044593	0.99	0.94	1.08	0.95	0.95	1.00	1.07	0.83	0.75	0.96	1.07	1.02	0.96	1.07	1.11	0.96	0.79	1.06
His	ME1044608	1.01	0.98	1.14	1.03	1.01	1.01	1.06	1.03	0.85	1.00	0.96	1.00	1.05	1.04	0.89	1.05	0.89	1.01
Met	ME1044598	1.01	0.95	1.21	1.10	0.88	1.04	0.87	1.00	0.86	1.01	1.04	1.03	1.05	1.08	0.84	0.92	0.86	0.95
Ser	ME1044606	1.00	1.19	1.18	1.04	0.99	1.07	0.83	0.83	0.95	0.70	0.91	0.94	0.94	1.06	1.05	1.13	0.88	0.95
Lys	ME1044610	0.90	1.05	1.17	1.14	0.95	1.14	0.85	1.16	1.07	0.93	0.87	1.02	1.05	0.99	0.89	1.10	0.88	1.01
Thr	ME1044604	0.89	1.04	1.03	1.23	0.97	0.98	0.63	1.10	1.00	0.83	0.97	1.01	1.05	1.06	0.83	1.02	0.77	1.00
Pro	ME1044600	1.32	0.90	1.29	1.16	0.95	0.89	0.41	1.23	0.52	1.02	0.94	1.14	1.04	1.07	0.63	1.03	1.03	0.83
Ala	ME1044603	1.09	1.03	1.28	1.35	0.77	1.05	0.81	0.89	0.67	0.98	1.05	1.02	1.12	0.93	0.69	0.81	0.88	0.90
Sar	ME1044601	1.10	1.05	1.27	1.34	0.78	1.07	0.80	0.89	0.68	0.99	1.04	1.01	1.12	0.93	0.69	0.81	0.88	0.90
Val	ME1044599	1.04	0.87	1.40	1.23	0.96	1.05	0.59	0.89	0.84	0.97	0.95	1.08	0.93	0.97	0.81	1.00	0.87	0.87
Ile	ME1044597	0.99	0.88	1.44	1.29	0.99	1.02	0.59	0.90	0.76	1.06	1.00	1.03	0.95	0.98	0.81	0.92	0.68	0.79
Leu	ME1044596	0.98	0.88	1.57	1.24	0.94	1.05	0.59	0.87	0.82	0.97	1.01	1.08	1.01	0.95	0.79	0.92	0.72	0.83
Nle	ME1044595	0.99	0.88	1.58	1.23	0.94	1.04	0.60	0.87	0.83	0.98	1.01	1.07	1.02	0.95	0.79	0.93	0.71	0.83
Creatine	ME1044602	1.13	0.77	1.02	1.10	1.04	1.18	0.41	1.21	1.80	1.11	0.89	0.95	1.31	1.06	0.77	0.95	0.84	0.96
Hyp	ME1044611	0.91	0.81	1.51	1.02	0.97	0.98	0.38	1.15	1.29	0.97	1.00	1.28	1.01	0.89	0.65	1.11	1.30	0.70

Factors:

F1	Subtype:Basal like \| Stage:III \| Sample source:Plasma
F2	Subtype:Basal like \| Stage:II \| Sample source:Plasma
F3	Subtype:Basal like \| Stage:NA \| Sample source:Plasma
F4	Subtype:Control \| Stage:Control \| Sample source:Plasma
F5	Subtype:HER2 \| Stage:III \| Sample source:Plasma
F6	Subtype:HER2 \| Stage:II \| Sample source:Plasma
F7	Subtype:HER2 \| Stage:I \| Sample source:Plasma
F8	Subtype:HER2 \| Stage:IV \| Sample source:Plasma
F9	Subtype:HER2 \| Stage:NA \| Sample source:Plasma
F10	Subtype:Luminal A \| Stage:III \| Sample source:Plasma
F11	Subtype:Luminal A \| Stage:II \| Sample source:Plasma
F12	Subtype:Luminal A \| Stage:I \| Sample source:Plasma
F13	Subtype:Luminal A \| Stage:NA \| Sample source:Plasma
F14	Subtype:Luminal B \| Stage:III \| Sample source:Plasma
F15	Subtype:Luminal B \| Stage:II \| Sample source:Plasma
F16	Subtype:Luminal B \| Stage:I \| Sample source:Plasma
F17	Subtype:Luminal B \| Stage:IV \| Sample source:Plasma
F18	Subtype:Luminal B \| Stage:NA \| Sample source:Plasma

Data matrix